Penicillin Allergy Test Verification Protocol
Penicillin allergy testing is performed through a structured process of skin testing followed by oral challenge in patients with negative skin tests, with the gold standard being a graded drug provocation test using the specific penicillin to which the patient previously reacted. 1
Initial Assessment
- History evaluation: Determine if testing is even necessary
Skin Testing Procedure
Preparation
- Ensure patient has not taken antihistamines recently:
- No chlorpheniramine/terfenadine within 24 hours
- No diphenhydramine/hydroxyzine within 4 days
- No astemizole within 3 weeks 1
Testing Protocol
Epicutaneous (Prick) Tests:
- Place duplicate drops of skin-test reagent on volar forearm
- Pierce epidermis with 26-gauge needle without drawing blood
- Positive result: wheal diameter ≥4 mm larger than negative control after 15 minutes 1
Intradermal Tests (if prick tests negative):
- Inject 0.02 mL of reagent into volar forearm using 26/27-gauge needle
- Positive result: wheal diameter >2 mm larger than initial wheal size and >2 mm larger than negative controls after 15 minutes 1
Testing Reagents
Standard panel (when available):
- Major determinant: Benzylpenicilloyl poly-L-lysine (Pre-Pen)
- Minor determinant mixture (MDM)
- Penicillin G 1
Limited panel (when full panel unavailable):
- Major determinant: Benzylpenicilloyl poly-L-lysine (Pre-Pen)
- Penicillin G 1
Controls:
- Positive control: Histamine
- Negative control: Saline 1
Risk Stratification
High-risk patients (history of anaphylaxis, asthma, beta-blocker use):
- Test with 100-fold dilutions before full-strength reagents
- Perform in monitored setting with anaphylaxis treatment available 1
Moderate-risk patients (non-anaphylactic immediate reactions within past year):
- Test with 10-fold dilutions before full-strength reagents 1
Interpretation and Next Steps
Skin test positive: Patient is allergic and should be desensitized if penicillin is needed 1
Skin test negative with full panel: Patient can safely receive conventional penicillin therapy (negative predictive value >95%) 1
Skin test negative with limited panel: Two approaches:
- Consider patient possibly allergic and proceed with desensitization
- Perform oral challenge with gradual dosing in monitored setting 1
Oral Challenge
- For patients with negative skin tests or low-risk histories
- Administer single treatment dose of amoxicillin under observation 1
- Monitor for reactions for at least 1 hour
Special Considerations
Delayed hypersensitivity reactions: Standard skin testing primarily detects IgE-mediated reactions; delayed readings may be needed for non-immediate hypersensitivity reactions 1
Declining sensitivity: Penicillin allergy may wane over time; approximately 90% of people with previous reactions eventually lose their sensitivity 1, 3
Testing accuracy: Skin testing has superior diagnostic accuracy (sensitivity 30.7%, specificity 96.8%) compared to in vitro specific IgE testing (sensitivity 19.3%, specificity 97.4%) 1
Pitfalls and Caveats
- Skin testing without minor determinants may miss 3-10% of allergic patients 1
- False negatives can occur if patient has recently taken antihistamines 1
- Testing should only be performed by trained personnel with preparedness to treat anaphylaxis 1
- Penicillin allergy labels are frequently incorrect and lead to suboptimal antibiotic choices, increased healthcare costs, and potentially worse outcomes 1, 3
By following this systematic approach to penicillin allergy testing, clinicians can accurately identify truly allergic patients while safely "delabeling" the approximately 90% of patients with reported penicillin allergy who can actually tolerate these antibiotics.